Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00032767
DRKS00032767
Recruiting
未知

Deep-phenotyping and personalized therapy of patients with irritable bowel syndrome - PIONEER-IBS

niversitätsklinikum Heidelberg, Abteilung für Allgemeine Innere Medizin und Psychosomatik0 sites75 target enrollmentOctober 20, 2023
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsF45.32K58Irritable bowel syndrome

Overview

Phase
未知
Intervention
Not specified
Conditions
F45.32
Sponsor
niversitätsklinikum Heidelberg, Abteilung für Allgemeine Innere Medizin und Psychosomatik
Enrollment
75
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 20, 2023
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversitätsklinikum Heidelberg, Abteilung für Allgemeine Innere Medizin und Psychosomatik

Eligibility Criteria

Inclusion Criteria

  • •\* Irritable bowel syndrome according to ROM\-IV criteria,
  • •\* Irritable bowel syndrome in clinical assessment,
  • •\* Patients who agree to participate in the study for at least 5 months,
  • •\* Written informed consent

Exclusion Criteria

  • •\* Severe psychopathology preventing group therapy (e.g. acute schizophrenic disorder, acute suicidality, current substance dependence (alcohol/drugs)).
  • •\* Psychopathology preventing short\-term EMDR treatment (e.g. severe dissociative symptoms (DES\-II \>25%), complex post\-traumatic stress disorder).
  • •\* Severe comorbid organic disorder preventing participation (e.g. palliative terminal cancer, serious nephrological, hepatic, cardiovascular or neurological disease).
  • •\*Pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials

Enrolling By Invitation
Not Applicable
PATient based phenotyping and evaluation of therapy for Rare Epilepsiesgenetic epilepsyORPHA:101998 Rare epilepsyORPHA:544254 SYNGAP1-related developmental and epileptic encephalopathyG40Epilepsy
DRKS00032075Institut für Rehabilitation, Transition und Palliation von neurologisch kranken Kindern der Paracelsus Medizinischen Privatuniversität Salzburg an der Schön Klinik Vogtareuth3,000
Enrolling By Invitation
Not Applicable
PATient based phenotyping and evaluation of therapy for RASopathies within the framework of the collaborative project EURAS – EURopean network for neurodevelopmental RASopathiesQ87.8Other specified congenital malformation syndromes, not elsewhere classified
DRKS00032923Institut für Humangenetik der medizinischen Fakultät der Otto-von-Guericke-Universität Magdeburg3,000
Not yet recruiting
Not Applicable
Clinical Deep Phenotyping of Treatment Response in Schizophrenia (CDP-STAR) Study
DRKS00034820Klinik für Psychiatrie und Psychotherapie der LMU München352
Not yet recruiting
Not Applicable
Clinical, biochemical and liver tissue changes in Hepatitis-B Gray zone patients and determine eligibility for treatment thereof.Health Condition 1: B181- Chronic viral hepatitis B withoutdelta-agent
CTRI/2023/12/060743I.P.G.M.R, Kolkata
Active, not recruiting
Not Applicable
Exploring detailed patient-specific biological analyses to personalise treatment in inflammatory bowel diseaseInflammatory Bowel DiseaseDigestive SystemCrohn’s disease, ulcerative colitis
ISRCTN65030013Imperial College London468